MEIS2 (15q14) gene deletions in siblings with mild developmental phenotypes and bifid uvula: documentation of mosaicism in an unaffected parent
- PMID: 34930369
- PMCID: PMC8690878
- DOI: 10.1186/s13039-021-00570-1
MEIS2 (15q14) gene deletions in siblings with mild developmental phenotypes and bifid uvula: documentation of mosaicism in an unaffected parent
Abstract
MEIS2 (Meis homeobox 2) encodes a homeobox protein in the three amino acid loop extension (TALE) family of highly conserved homeodomain-containing transcription regulators important for development. MEIS2 deletions/mutations have been associated with cleft lip/palate, dysmorphic facial features, cardiac defects, as well as intellectual disability at a variable severity. Here we report on one familial case that two affected siblings carry the same non-mosaic ~ 423 kb genomic deletion at 15q14 encompassing the entirety of CDIN1 and the last three exons (ex. 10, 11, 12) of the MEIS2 gene, while their unaffected father is mosaic for the same deletion in about 10% lymphocytes. Both siblings presented with mild developmental delay and bifid uvula, while no congenital cardiac abnormalities were identified. The elder sister also showed syncopal episodes and mild speech delay and the father had atrial septal defects. This is the first report showing multiple family members inherit a genomic deletion resulting in a MEIS2 partial truncation from a mosaic parent. Taken all together, this study has important implications for genetic counseling regarding recurrence risk and also points to the importance of offering MEIS2 gene tests covering both point mutations and microdeletions to individuals with milder bifid uvula and developmental delay.
Keywords: Chromosome microarray; Deletion; Developmental delay; Dosage effect; FISH; MEIS2; Mosaicism; Orofacial clefts.
© 2021. The Author(s).
Conflict of interest statement
The authors have declared that no competing interests.
Figures

Similar articles
-
MEIS2 sequence variant in a child with intellectual disability and cardiac defects: Expansion of the phenotypic spectrum and documentation of low-level mosaicism in an unaffected parent.Am J Med Genet A. 2021 Jan;185(1):300-303. doi: 10.1002/ajmg.a.61929. Epub 2020 Oct 22. Am J Med Genet A. 2021. PMID: 33091211
-
Haploinsufficiency of MEIS2 is associated with orofacial clefting and learning disability.Am J Med Genet A. 2014 Jul;164A(7):1622-6. doi: 10.1002/ajmg.a.36498. Epub 2014 Mar 26. Am J Med Genet A. 2014. PMID: 24678003
-
Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.Eur J Hum Genet. 2019 Feb;27(2):278-290. doi: 10.1038/s41431-018-0281-5. Epub 2018 Oct 5. Eur J Hum Genet. 2019. PMID: 30291340 Free PMC article.
-
De novo MEIS2 mutation causes syndromic developmental delay with persistent gastro-esophageal reflux.J Hum Genet. 2016 Sep;61(9):835-8. doi: 10.1038/jhg.2016.54. Epub 2016 May 26. J Hum Genet. 2016. PMID: 27225850 Review.
-
Heart defects and other features of the 22q11 distal deletion syndrome.Eur J Med Genet. 2013 Feb;56(2):98-107. doi: 10.1016/j.ejmg.2012.09.009. Epub 2012 Oct 10. Eur J Med Genet. 2013. PMID: 23063575 Review.
Cited by
-
Multi-omics analysis detail a submicroscopic inv(15)(q14q15) generating fusion transcripts and MEIS2 and NUSAP1 haploinsufficiency.Sci Rep. 2024 Dec 5;14(1):30343. doi: 10.1038/s41598-024-81507-7. Sci Rep. 2024. PMID: 39639090 Free PMC article.
-
Long read Nanopore sequencing identifies precise breakpoints of a de novo paracentric inversion that disrupt the MEIS2 gene in a Chinese girl with syndromic developmental delay.BMC Pediatr. 2025 Jan 9;25(1):18. doi: 10.1186/s12887-024-05267-z. BMC Pediatr. 2025. PMID: 39789493 Free PMC article.
References
-
- Panamonta V, et al. Global birth prevalence of orofacial clefts: a systematic review. J Med Assoc Thai. 2015;98(Suppl 7):S11–21. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials